ÍøºìºÚÁÏ

Skip to main content
(352) 294-5480

Kartik Cherabuddi, MD, FACP, FIDSA, FIDSA

Infectious Disease Specialist

Photo of Kartik Cherabuddi
(352) 294-5480 MyUFÍøºìºÚÁÏ

Research at a glance

Top areas of exploration

  • Anti-Bacterial Agents , 10 publications
  • COVID-19 , 5 publications
  • Cross Infection , 4 publications
  • Cefepime , 3 publications

Research activity

69 publications

1,190 citations

Why is this important?

Focus

Multidrug resistant infections

Antimicrobial alternatives to antibiotics

Therapeutic drug monitoring and personalized medicine

Emerging global infections

NTM infections in Transplant patients

Infectious disease fellow, Internal medicine resident and Medical student education

Active clinical trials

RECOVER-AD

This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community settings where it can be integrated into COVID-19 programs and subsequent treatment plans. This…

Investigators
Vidhu Kariyawasam, Kartik Cherabuddi
Status
Accepting Candidates
Ages
18 Years - N/A
Sexes
All

My publications

69 publications

2025

A Case Cluster of Aseptic Meningitis Associated With a Newly Identified Recombinant Echovirus 6/Coxsackievirus B1 Enterovirus

The Journal of Infectious Diseases

2025

Development and implementation of learning collaboratives for infection prevention and control education in long-term care facilities.

American journal of infection control

•

2025

Impact of Timing of Beta-Lactam Therapeutic Drug Monitoring and Therapy Adjustment in Critically Ill Patients

Antibiotics

•

2025

Infection prevention and control in long-term care facilities in Florida: A needs assessment survey.

American journal of infection control

•

2024

Brincidofovir for disease progression due to suspected tecovirimat resistance in association with advanced HIV.

International journal of STD & AIDS

•